TorMagnus Pharmaceuticals
About:
TorMagnus Pharmaceuticals is a drug discovery firm dedicated to discovering treatments for Peroxisomal disorders.
Website: https://www.tormagnuspharmaceuticals.com
Top Investors: Y Combinator
Description:
TorMagnus Pharmaceuticals combines graph theory and network medicine approaches to use AI to aid in the identification of novel drug treatments. The immediate focus is on identifying targets for Parkinson's disease.
Total Funding Amount:
$500000
Headquarters Location:
San Francisco, California, United States
Founded Date:
2022-05-01
Contact Email:
contact(AT)tormagnuspharma.com
Founders:
John Fraser, Talia Krainc
Number of Employees:
1-10
Last Funding Date:
2023-04-05
IPO Status:
Private
Industries:
© 2025 bioDAO.ai